CSS
BNTX icon

Cubist Systematic Strategies’s BioNTech BNTX Stock Holding History

Cubist Systematic Strategies’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,626
Closed -$277K – 3741
2023
Q4 		$277K Buy
+2,626
New +$265K ﹤0.01% 2823
2023
Q3 		– Sell
-14,757
Closed -$1.63M – 3362
2023
Q2 		$1.59M Sell
14,757
-52,126
-78% -$5.86M 0.01% 1654
2023
Q1 		$8.33M Buy
66,883
+49,871
+293% +$6.85M 0.05% 561
2022
Q4 		$2.56M Buy
17,012
+11,361
+201% +$1.75M 0.01% 1643
2022
Q3 		$762K Sell
5,651
-11,188
-66% -$1.71M ﹤0.01% 2845
2022
Q2 		$2.51M Buy
16,839
+4,749
+39% +$726K 0.02% 1638
2022
Q1 		$2.06M Buy
12,090
+5,477
+83% +$920K 0.02% 1450
2021
Q4 		$1.71M Sell
6,613
-1,019
-13% -$279K 0.02% 1506
2021
Q3 		$2.08M Sell
7,632
-2,290
-23% -$728K 0.03% 985
2021
Q2 		$2.22M Buy
+9,922
New +$1.87M 0.03% 1015
2021
Q1 		– Sell
-3,881
Closed -$316K – 2836
2020
Q4 		$316K Buy
+3,881
New +$381K ﹤0.01% 2006

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Cubist Systematic Strategies's BNTX Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 2,626 shares — an estimated $277K sold.

Cubist Systematic Strategies first reported a position in BNTX in Q4 2020 and held it in 11 quarters. The position peaked at $8.33M in Q1 2023. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 2,626 BioNTech shares in Q1 2024, an estimated $277K.
  • Cubist Systematic Strategies first reported a position in BioNTech in Q4 2020 and held it in 11 quarters.
  • Cubist Systematic Strategies's BioNTech position peaked at $8.33M in Q1 2023.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.